Related Experiment Video
Updated: Jun 5, 2026

Microscopy-based Assays for High-throughput Screening of Host Factors Involved in Brucella Infection of Hela Cells
Published on: August 5, 2016
Antimicrobial susceptibility of Brucella melitensis isolates in Peru
Ryan C Maves1, Rosa Castillo, Alfredo Guillen
1Division of Infectious Diseases, Naval Medical Center San Diego, 34800 Bob Wilson Drive, San Diego, CA 92134, USA. Ryan.Maves@med.navy.mil
Abstract:
Brucellosis is an important public health problem in Peru. We evaluated 48 human Brucella melitensis biotype 1 strains from Peru between 2000 and 2006. MICs of isolates to doxycycline, azithromycin, gentamicin, rifampin, ciprofloxacin, and trimethoprim-sulfamethoxazole were determined by the Etest method. All isolates were sensitive to tested drugs during the periods of testing. Relapses did not appear to be related to drug resistance.
Insights
Brucellosis treatment in Peru showed all tested bacteria were sensitive to common antibiotics. This suggests drug resistance is not a primary cause of patient relapses in this region.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Brucellosis poses a significant public health challenge in Peru.
- Brucella melitensis biotype 1 is a common cause of human brucellosis.
Purpose of the Study:
- To evaluate the antimicrobial susceptibility of Brucella melitensis biotype 1 strains isolated from human cases in Peru.
- To investigate the potential relationship between antimicrobial resistance and brucellosis relapses.
Main Methods:
- Antimicrobial susceptibility testing was performed using the Etest method.
- Minimum Inhibitory Concentrations (MICs) were determined for doxycycline, azithromycin, gentamicin, rifampin, ciprofloxacin, and trimethoprim-sulfamethoxazole.
- 48 human Brucella melitensis biotype 1 isolates from Peru (2000-2006) were analyzed.
Main Results:
- All 48 evaluated Brucella melitensis isolates were sensitive to the tested antibiotics.
- No drug resistance was observed in the isolates during the study period.
- Brucellosis relapses were not found to be associated with antimicrobial resistance.
Conclusions:
- The tested Brucella melitensis strains in Peru remained susceptible to key antibiotics between 2000 and 2006.
- Antimicrobial resistance does not appear to be a major factor contributing to brucellosis relapses in this population.
- Continued surveillance of antimicrobial susceptibility is important for effective brucellosis management in Peru.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Antiprotozoal Agents
